DK222 Study at Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
BeOne Medicines
ViroMissile, Inc.
Arcus Biosciences, Inc.
Tizona Therapeutics, Inc
Clasp Therapeutics, Inc.
Eli Lilly and Company
Baylor College of Medicine
MacroGenics
City of Hope Medical Center
Eli Lilly and Company
IDEAYA Biosciences
National Institutes of Health Clinical Center (CC)
Pfizer
University Health Network, Toronto
NeoTX Therapeutics Ltd.
IDEAYA Biosciences
Rondo Therapeutics
Actym Therapeutics, Inc.
Jonsson Comprehensive Cancer Center
Incyte Corporation
Trishula Therapeutics, Inc.
Incyte Corporation
Genentech, Inc.
Trishula Therapeutics, Inc.
Monopar Therapeutics
Monopar Therapeutics
Revolution Medicines, Inc.
Seagen Inc.
Sotio Biotech Inc.
Carisma Therapeutics Inc
Acepodia Biotech, Inc.
Keythera (Suzhou) Pharmaceuticals Co. Ltd
Eli Lilly and Company
Xencor, Inc.
ADC Therapeutics S.A.
Pfizer
STCube, Inc.
Zhejiang University
Adaptimmune
Corvus Pharmaceuticals, Inc.
Rutgers, The State University of New Jersey
Centre Georges Francois Leclerc
Emory University
Canadian Cancer Trials Group
Viralytics
Evelo Biosciences, Inc.
Bristol-Myers Squibb
Quadriga Biosciences, Inc.
Revolution Medicines, Inc.